Colorectal cancer ▲ Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)






Last Updated: Nov 03, 2016

• BRAF Mutation Testing and Metastatic Colorectal Cancer in the Community Setting: Is There an Urgent Need for More Education?
  Price Timothy J et al. Molecular diagnosis & therapy 2016 Feb 20(1) 75-82
• Cost-effectiveness of routine screening for Lynch syndrome in endometrial cancer patients up to 70years of age.
  Goverde Anne et al. Gynecologic oncology 2016 Oct
• [Can the weekday of surgery influence the prognosis of colorectal cancer patients? A retrospective study based on a single-center of large sample].
  Li Yaqi, et al. Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery 2016 10 (10) 1129-1132
• Aberrant DNA methylation of acute myeloid leukemia and colorectal cancer in a Chinese pedigree with a MLL3 germline mutation.
  Yang Fuhua, et al. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2016 9 (9) 12609-12618
• Triple Therapy Improves Colorectal Cancer Response.
  Cancer discovery 2016 10
• Risk of eighteen genome-wide association study-identified genetic variants for colorectal cancer and colorectal adenoma in Han Chinese.
  Tan Chunwen, et al. Oncotarget 2016 10
• A novel variant on chromosome 6p21.1 is associated with the risk of developing colorectal cancer: a two-stage case-control study in Han Chinese.
  Xu Chunxiao, et al. BMC cancer 2016 10 (1) 807
• Alanine to Serine Variant at Position 986 of Calcium Sensing Receptor and Colorectal Cancer Risk.
  Dabiri Reza, et al. Iranian journal of cancer prevention 2016 8 (4) e8098
• Prevalence of Lynch syndrome in unselected patients with endometrial or ovarian cancer.
  Kast Karin, et al. Archives of gynecology and obstetrics 2016 11 (6) 1299-1303
• Spatio-temporal mutation profiles of case-matched colorectal carcinomas and their metastases reveal unique de novo mutations in metachronous lung metastases by targeted next generation sequencing.
  Kovaleva Valentina, et al. Molecular cancer 2016 10 (1) 63
• Association between microRNA-27a rs895819 polymorphism and risk of colorectal cancer: A meta-analysis.
  Liu Feifei, et al. Cancer genetics 2016 9 (9) 388-394
• Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study.
  Simons Colinda C J M, et al. International journal of cancer 2016 9
• TCF7L2 and CCND1 polymorphisms and its association with colorectal cancer in Mexican patients.
  Rosales-Reynoso M A, et al. Cellular and molecular biology (Noisy-le-Grand, France) 2016 9 (11) 13-20
• Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer.
  Thomsen Maria, et al. Oncotarget 2016 10
• A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer.
  Kim Tae Won, et al. British journal of cancer 2016 10

• CDC Information (9)
• CDC-Authored Pub (13)

• Human (58)
• Pathogen (5)

• Human (4115)
• Pathogen (0)

• Human (245)
• Pathogen (0)

• Guidelines (16)
• Tier Table (19)
• Synthesis (58)

• Huamn (76)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB